Essay
Argued that an incoming pharma patent cliff makes 2026 a good year to fund early-stage biotech.
A New Patent Cliff Is Coming: The Buy Signal For Biotech
Essay
Published an essay on how AI may change patent and IP strategy.
The Patent Time Bomb: How AI Might Rewrite IP Strategy
APR 27, 2026